Form D · Biotechnology
CryptoMedix, Inc.
Harpswell, ME · CIK 0001663510
Offering snapshot reported Jun 8, 2016 · SEC filing
- Reported sold
- $277K Offering amount: $500K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Jan 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 7
- Minimum accepted$1,000 → $500
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2016 | Amendment | $276,500 | No comparison | 7 | SEC filing |
| Jan 19, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255393
promissory notes convertible into shares of preferred stock
Source: Form D, filed Jun 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bob Davis | Director |
| Leonard Liebes | Director |
| Bernd Seizinger | Director, Executive |
| Bob Suva | Director |
| Janet Yancey Wrona | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
464 Basin Point Road
Harpswell, ME, 04079
Harpswell, ME, 04079